Choosing between genomic data cloud storage and on-premise infrastructure is a decision that looks like a simple price comparison and is not, because the two options have fundamentally different cost structures that behave differently over time and under different access patterns. Cloud looks cheaper at the outset, and for a lab just starting to accumulate data it often is. But the comparison that matters is not the monthly storage rate in year one; it is the total cost over the life of the data, including the cost of getting it back out, and that fuller comparison can reverse the ranking by year three. Add the compliance and data-residency constraints that genomic data specifically carries, and the decision becomes one that has to be made on cost structure and control together, not on headline storage price.

This article compares cloud, on-premise, and hybrid infrastructure for genomic data across the dimensions that actually decide it: how the two cost structures differ, the egress charges that are easy to miss and hard to escape, the way compute demand bursts around runs, the compliance and residency constraints that apply to human genomic data, and the hybrid architectures that resolve the tradeoff for many labs. The sizing that feeds this decision, how much data you are actually storing, is covered in How Big Is NGS Data? Sizing Storage for Your Sequencing Volume.

How the Two Cost Structures Differ

The core difference is not which is cheaper but how each one costs money, because that shape determines which is cheaper for a given lab. On-premise storage is a capital purchase: you buy the hardware, house it, power and cool it, maintain it, and replace it on a refresh cycle, paying a large sum up front and then a smaller ongoing operating cost. It scales in steps, since adding capacity means buying more hardware in chunks, and reading your own data costs nothing beyond the electricity. Cloud storage inverts this: it is an operating cost with little or no capital outlay, billed monthly for what you use, scaling smoothly with no need to provision ahead, but with per-access and data-transfer charges layered on top of the storage rate.

These shapes suit different situations. Cloud favors a lab with unpredictable or growing needs, limited capital, and the desire to avoid managing hardware, since it turns a large up-front commitment into a variable monthly cost that tracks actual use. On-premise favors a lab with steady, high, predictable volume and the capital to buy ahead, since owning the hardware eliminates the recurring per-gigabyte and per-access charges that accumulate relentlessly in the cloud at scale. The mistake is comparing them on the year-one storage rate alone, because that single number hides the charges that dominate the comparison over the life of the data.

Table 1. Cloud and on-premise infrastructure differ less in headline price than in cost structure. The right choice depends on your access pattern and growth, not on the monthly storage rate alone.

Advanced Lab Management Certificate

The Advanced Lab Management certificate is more than training—it’s a professional advantage.

Gain critical skills and IACET-approved CEUs that make a measurable difference.

Egress and the Hidden Line

The single most overlooked line in a cloud genomics budget is egress, the charge for moving data out of the cloud, and it is overlooked precisely because the pricing is asymmetric in a way that hides it at the start. Uploading data into the cloud is free on the major providers. Moving it back out, to your own systems, to another provider, or to a collaborator, is charged per gigabyte, and the rates run from a few cents to around nine cents per gigabyte on the major providers depending on volume, falling somewhat at higher tiers. Providers charge several times more to retrieve data than to store it for a month, an asymmetry that is not accidental: it is the mechanism that makes moving data out, or moving providers, expensive.

For genomic data, where files are large, this compounds quietly. A lab that stores its data in the cloud and analyzes it in the cloud may rarely pay egress; a lab that stores in the cloud but repeatedly pulls data back to local compute, shares large datasets with external collaborators, or ever decides to migrate away pays egress every time. Terabytes of genomic data moved out at cents per gigabyte adds up to real money, and it is the line that most often reverses an apparent cloud cost advantage in the second or third year, once the data has accumulated and the access pattern is established.

Interested in lab tools and techniques?

Register for a FREE Lab Manager account to subscribe to our Lab Tools & Techniques Newsletter.

Subscribe for Free

Compute Bursting and Peak Demand

Storage is only half the infrastructure decision; the other half is compute, and here the cost structures favor cloud in a way storage alone does not. Sequencing compute demand is bursty: it concentrates in the hours after a run completes, when analysis runs, and falls to little between runs. That pattern suits cloud’s elastic, on-demand model well and suits a fixed on-premise cluster poorly, because an on-premise cluster sized for the peak sits idle between runs, while one sized for the average cannot keep up when a run completes. Cloud lets a lab pay for peak compute only when it is needed and nothing when it is not, which for a bursty workload can be markedly more efficient than owning hardware for a peak that occurs a few hours a week.

This is why the storage and compute decisions can land differently, and often do. A lab may find that steady, heavily accessed storage argues for keeping data on-premise while bursty analysis argues for cloud compute, which is one of the main reasons hybrid architectures exist. The way this compute-burst pattern interacts with run scheduling and how analysis capacity is provisioned is developed in Managing NGS Data: Storage, Compute, Retention, and Staffing.

Compliance, Residency, and Consent Constraints

Human genomic data is not ordinary data, and the constraints that apply to it can override a pure cost decision, so they have to be established before infrastructure is chosen rather than discovered afterward. Genomic data from identifiable individuals is sensitive personal information and, in many frameworks, a special category subject to heightened protection, and where it may be stored and processed is governed by law, by institutional policy, and by the consent under which the samples were collected. These constraints are real, they differ by jurisdiction, and they are worth stating plainly rather than hedging.

In Canada, the federal private-sector law, the Personal Information Protection and Electronic Documents Act, works on an accountability model rather than a strict data-localization one: it does not, by itself, require that personal information physically remain in Canada, but it holds the organization accountable for comparable protection wherever the data is processed, so a cross-border cloud arrangement requires appropriate contractual safeguards. The harder residency requirements in Canada come from the provincial and sectoral level. Quebec’s Law 25 requires a privacy impact assessment before personal information is transferred outside the province; British Columbia and Nova Scotia have public-sector residency rules; health information is governed by provincial health-privacy laws such as Ontario’s; and government and healthcare contracts frequently require Canadian residency regardless of what the federal statute permits. A lab handling Canadian health-linked genomic data should confirm its specific provincial and contractual obligations before assuming cross-border storage is available.

In the European Union, the General Data Protection Regulation restricts transferring personal data outside the European Economic Area unless the destination has an adequacy decision or appropriate safeguards such as standard contractual clauses are in place, and it treats genetic and health data as a special category subject to additional protection. A lab operating in or handling data from the EU has to satisfy those transfer rules before placing genomic data in a cloud region outside the EEA. The specific obligations that apply to any given lab depend on its jurisdiction, its funders, and the consent its samples were collected under, and this article is a map of the considerations rather than legal advice; confirm the rules that bind your particular situation with someone qualified to interpret them. How these residency questions connect to retention and deletion policy is developed in Data Retention, Backup, and Archiving Policy for Sequencing Labs.

Hybrid Architectures That Work

For many sequencing labs the honest answer is not cloud or on-premise but a deliberate combination, because the two cost structures suit different parts of the data lifecycle, and a hybrid architecture assigns each part to where it fits best. The common and effective pattern keeps active data, the runs currently being analyzed, on fast local storage next to the compute that processes it, avoiding egress and per-access charges on the data being worked hardest, while tiering older, rarely accessed data out to cheaper cloud archive under a lifecycle policy. This keeps the frequently touched data fast and free of retrieval charges and pushes the long tail of cold data to the cheapest durable storage, capturing the strengths of both.

The design discipline that makes a hybrid work is matching each class of data to the environment that fits its access pattern and its constraints, rather than defaulting everything to one or the other. Active data local, cold data in the cloud, compute burst to the cloud when analysis demands it, and anything under a hard residency constraint placed where the law requires. Getting that assignment right is the whole art of it, and how the whole program’s economics fit together is in Next-Generation Sequencing in the Lab: A Manager’s Guide to Building, Budgeting, and Scaling NGS Capacity.

This article was produced under Lab Manager's AI Editorial Guidelines.